Pharmather Enters Exclusive Arrangement For Psychedelic Delivery Tech
Pharmather Inc (CSE: PHRM) this morning announced that it has entered into an exclusive license agreement for the development and
Read more
Pharmather
Pharmather Applies For Orphan Drug Status For Ketamine In Use Against Parkinson’s Disease
Pharmather Inc (CSE: PHRM) has filed for orphan drug designation with the US Food and Drug Administration for the use
Read more
Pharmather Acquires Exclusive License For Ketamine Treatment Against Parkinson’s Disease
Pharmather Inc (CSE: PHRM) this morning announced that it has entered into an exclusive licensing agreement for the development and
Read more
Pharmather: Combining Artificial Intelligence With Psychedelics For Novel Drug Discovery
Newscope Capital, whom is currently doing business as Pharmather (CSE: PHRM) is the latest firm to begin trading on the
Read more